Regulatory Roundup: Top News Stories – Week Ending August 11, 2017

There have not been any new drug approvals so far this week but the FDA granted a few new Orphan Drug Designations and Priority Reviews. Here is my summary of the top regulatory news stories this week for pharma and biotech: The FDA is on track for most generic drug approvals ever for Fiscal Year[…]